Adalvo acquires its first branded product, Onsolis® – NBCNEWS

  • Whatsapp

Business Wire India

Read More

Global pharmaceutical company Adalvo today announced the acquisition of its first branded product, Onsolis®, after signing a deal with a renowned US specialty pharmaceutical company that originally owned the product.

The brand is an opioid analgesic indicated for the treatment of persistent breakthrough pain in cancer patients who have already received opioid therapy and are tolerant of their underlying cancer pain. Adalvo becomes the sole and exclusive owner of the brand and obtains full rights to the product, taking over all existing activities and all marketing licenses worldwide, including in the US.

The brand is currently sold by business partners in several EU countries and in Taiwan. Adalvo will assume delivery responsibility and business continuity for these partners.

“This acquisition paves the way for a transformative journey at Adalvo. It’s a real game-changer and we’re excited to venture into the branded space and expand our position as a preferred global partner,” said Anil Okay, CEO of Adalvo. “Our business continues to be fueled by our passion for an unwavering commitment to the partner network we serve, and we will continue to add high-value assets to our portfolio, now venturing into the branded realm.”

About Adalvo

Adalvo is a global pharmaceutical company and one of the leading B2B pharmaceutical companies in Europe, with commercial partnerships in more than 70 countries and for more than 90 commercial partners worldwide. The company’s stated purpose is to make a difference for patients around the world, driven by our smart collaboration network and our commitment to deliver the highest quality differentiated products and services to our partners. Headquartered in Malta, the company has additional offices in more than 15 countries, such as Switzerland, UK, Netherlands, Spain, Iceland, Austria, Romania, Hungary, Bulgaria, Portugal, Czech Republic and India. At Adalvo, we know that our partners like to be bigger, better and smarter in the dynamic pharmaceutical industry. That’s why our approach is unique, tailored for our partners and designed to challenge the status quo: together it helps our partners achieve their business goals. We pride ourselves on our ability to help its partners achieve their goals – whether it’s increasing revenue or entering new markets. While partners are a high priority, Adalvo is also committed to its purpose and mission to accelerate the growth and development of employees and local communities. Adalvo tirelessly strives for excellence in all its endeavors, driven by a deep-rooted passion to make a difference for partners. The company’s purpose-driven culture is committed to improving the lives of patients around the world. Our dynamic leadership team brings significant experience and industry knowledge to Adalvo, which has helped establish the company as a trusted global partner.


Content is from Business Wire India. DKODING Media is not responsible for the content offered or any links related to this content. DKODING Media is not responsible for the accuracy, timeliness or quality of the content.

Related posts

Leave a Reply